Apalutamide

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Apalutamide
CAS No.:956104-40-8
Standard:ChP, USP, BP, EP, JP, In-house Standards, IP, Ph. Int
Price(USD):Negotiable
Company:Quanzhou Fortune Biopharma Co.,Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Quanzhou

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: L/C

    Apalutamide is a second-generation highly selective androgen receptor antagonist, and its affinity with androgen receptors is more than 5 times that of the first-generation androgen receptor antagonists. A phase III study involving 1207 patients with non-metastatic castration-resistant prostate cancer demonstrated that apalutamide significantly prolonged metastasis-free survival (40.5 vs 16.2 months) compared with placebo. 2018/2/14, Apalutamide was approved by the FDA for the treatment of non-metastatic (prostate cancer cells have not spread) castration-resistant prostate cancer (the disease still progresses after hormone therapy)

Send your message to this supplier
  • From:
  • To:
    Quanzhou Fortune Biopharma Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service